The short version
- Why people research itCognitive ageing, kidney and vascular health, and lifespan — on mouse genetics and one primate study, with no human administration data at all.
- What the evidence isNo randomized human trials — a research compound with no commercial route to funding one, so the correlative and theoretical tiers are the evidence base rather than a consolation prize.
- What to watchBone pain or muscle weakness, the low phosphate pattern.
How Klotho works
The first thing to understand about Klotho is its size, because almost everything else follows from it. Klotho is not a peptide.
There are two Klothos and conflating them is the commonest error made about it. Membrane Klotho, anchored by that transmembrane helix, is an obligate co-receptor: FGF23 binds FGF receptors with very low affinity on their own, and Klotho is what confers the affinity and the tissue specificity. That complex is how the kidney is told to excrete phosphate.
A soluble form is shed into blood and CSF. It is the obligate co-receptor that lets FGF23 signal, which is how it governs phosphate and vitamin D handling, and separately it dampens insulin/IGF-1 and Wnt signaling and raises resistance to oxidative stress. Klotho falls with age and falls further in chronic kidney disease.
- Injectable
Research on Klotho7 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
No randomized human trials — a research compound with no commercial route to funding one, so the correlative and theoretical tiers are the evidence base rather than a consolation prize.
No completed human trial
Correlative data
Low circulating Klotho tracks with almost everything that gets worse with age. Observational cohorts link lower serum alpha-Klotho to chronic kidney disease progression, cardiovascular events, arterial stiffening, and poorer cognitive scores. These are associations in people who were never given Klotho, and low Klotho is downstream of kidney damage — so a large part of the signal may be reporting kidney health rather than an independent effect.
A common variant of the KL gene (the KL-VS haplotype) associates with higher circulating Klotho and, in several cohorts, with better cognitive ageing and longer life in carriers of one copy. Notably the effect is not linear.
How the mechanism reads
The mouse genetics are unusually clean, in both directions. Disrupting Klotho produces a syndrome that looks like accelerated ageing — short lifespan, vascular calcification, osteoporosis, skin atrophy — and overexpressing it extends mouse lifespan. Two-way evidence like that is rare and is the whole reason anyone cares about this protein.
Experimental, animal or cellImportantly. And it means 'more' is a specific hypothesis to test, not a safe default.
Experimental, animal or cellMechanistically it sits upstream of several pathways already targeted elsewhere in this Vault: it is required for FGF23 signaling, it suppresses insulin/IGF-1 signaling, and it inhibits Wnt. That breadth is what makes it interesting and also what makes off-target effects hard to predict.
MechanisticNothing here has been tested in a human being. Every number for human use is an extrapolation across two species boundaries.
Mechanistic
Sources
- UniProt Consortium. UniProtKB Q9UEF7 (KLOT_HUMAN) — Klotho, gene KL, EC 3.2.1.31: 1012 amino acids, signal peptide 1-33, transmembrane helix 982-1002, and two glycosyl hydrolase family 1 regions at 57-506 and 515-953. UniProt Knowledgebase, reviewed entry, release 2026
- Kanbay M, et al. Klotho: a potential therapeutic target in aging and neurodegeneration beyond chronic kidney disease-a comprehensive review from the ERA CKD-MBD working group. Clinical Kidney Journal 2024 · PMID 38213484
- Prud'homme GJ, Kurt M, Wang Q. Pathobiology of the Klotho Antiaging Protein and Therapeutic Considerations. Frontiers in Aging 2022 · PMID 35903083
- Hanson K, Fisher K, Hooper NM. Exploiting the neuroprotective effects of alpha-klotho to tackle ageing- and neurodegeneration-related cognitive dysfunction. Neuronal Signaling 2021 · PMID 34194816
Klotho safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Kidney stones or low blood phosphate.
- Allergy to recombinant proteins, because it is a large foreign protein.
- Active cancer, since Klotho's growth-factor interactions are not fully mapped.
- Pregnancy, since FGF23 and phosphate control matter for fetal bone.
- Chronic kidney disease, where FGF23 and phosphate balance is already unstable.
What’s expected
- Shifts in how phosphate, calcium and vitamin D are handled, via FGF23 signaling.
- Neuroprotective effects in animal models.
- Antibody formation against a recombinant protein is possible.
Watch for
- Bone pain or muscle weakness, the low phosphate pattern.
- Hives or throat swelling.
- Kidney stone pain.
Labs that tell you it’s working
- Parathyroid Hormone & Calcium: FGF23 and Klotho signaling shifts PTH and calcium.
- Vitamin D (25-Hydroxy): Klotho and FGF23 govern 1,25-D production.
- Comprehensive Metabolic Panel: phosphate and creatinine.
- Cystatin C with eGFR: Klotho is made mostly in the kidney.
Alpha-Klotho protein: obligate FGF23 co-receptor governing phosphate and vitamin D, plus anti-ageing signaling; no recombinant form has a published human trial. PMID 38213484 PMID 35903083
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Klotho FAQ4 common questions
- Is Klotho approved for human use?
- No. Klotho is a research compound. No completed randomized human trial has given it yet.
- What is Klotho researched for?
- Cognitive ageing, kidney and vascular health, and lifespan — on mouse genetics and one primate study, with no human administration data at all.
- Which labs show whether it's doing anything?
- Parathyroid Hormone & Calcium; Vitamin D; Comprehensive Metabolic Panel; Cystatin C with eGFR: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Klotho: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



